FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, namely to isolated amniotic adhesive human cell, to population and composition, which contain such cells, as well as to methods of obtaining such cells and methods of applying said cells in treatment of individuals. Said cell is adhesive to plastic for tissue cultures. Said cell is OCT-4 (octamer-binding protein 4) by RT-PCR. Said cell represents CD49f+, CD90+ and HLA-G- by flow cytometry data. Said cell is angiogenic.
EFFECT: claimed invention makes it possible to obtain novel angiogenic isolated amniotic adhesive human cell.
31 cl, 18 dwg, 8 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STROKE TREATMENT WITH APPLICATION OF ISOLATED PLACENTAL CELLS | 2009 |
|
RU2558778C2 |
| IMPROVED CELL COMPOSITION AND METHODS OF OBTAINING THEREOF | 2009 |
|
RU2563518C2 |
| IMPROVED CELL COMPOSITION AND METHODS FOR ITS PREPARATION | 2009 |
|
RU2662676C1 |
| TREATMENT OF DISEASE, DISORDERS OR PATHOLOGICAL CONDITIONS OF LUNGS WITH APPLICATION OF PLACENTAL CELLS | 2009 |
|
RU2570550C2 |
| TREATING DISEASES, DISORDERS OR PATHOLOGICAL CONDITIONS OF THE LUNGS USING PLACENTAL CELLS | 2009 |
|
RU2732240C2 |
| SUPPRESSION OF TUMORS USING HUMAN PLACENTA DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATING COMPOUNDS | 2010 |
|
RU2742171C2 |
| TUMOUR SUPPRESSION WITH APPLICATION OF INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS OBTAINED FROM HUMAN PLACENTA | 2010 |
|
RU2642988C2 |
| METHODS FOR PRODUCING TISSUES | 2013 |
|
RU2733838C2 |
| TUMOUR SUPPRESSION WITH USE OF HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS RECOVERED FROM HUMAN PLACENTA | 2008 |
|
RU2536242C2 |
| SUPPRESSION OF TUMORS USING HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS ISOLATED FROM HUMAN PLACENTA | 2008 |
|
RU2781543C2 |
